Gene · 23643
Papers4,579
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 4,579
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Developing a Novel Immune-Related Seven-Gene Signature and Immune Infiltration Pattern in Patients with COVID-19 and Cardiovascular Disease. | J Cardiovasc Dev Dis | 2022 | 36547446 | PubTator, text mining | PubMed |
| Comparison of ischemic stroke diagnosis models based on machine learning. | Front Neurol | 2022 | 36545400 | PubTator, text mining | PubMed |
| Identification of key genes of anti-programmed death ligand 1 for meningioma immunotherapy by bioinformatic analysis. | Med Oncol | 2022 | 36538194 | PubTator, text mining | PubMed |
| The repertoire of protein-sulfatide interactions reveal distinct modes of sulfatide recognition. | Front Mol Biosci | 2022 | 36533082 | PubTator, text mining | PubMed |
| A novel uveitis model induced by lipopolysaccharide in zebrafish. | Front Immunol | 2022 | 36532084 | PubTator, text mining | PubMed |
| Alternative pre-mRNA splicing as a mechanism for terminating Toll-like Receptor signaling. | Front Immunol | 2022 | 36531997 | PubTator, text mining | PubMed |
| The relationship between 896A/G (rs4986790) polymorphism of TLR4 and infectious diseases: A meta-analysis. | Front Genet | 2022 | 36506333 | PubTator, text mining | PubMed |
| Placental macrophage responses to viral and bacterial ligands and the influence of fetal sex. | iScience | 2022 | 36505933 | PubTator, text mining | PubMed |
| Comprehensive Pan-Cancer Analyses of Immunogenic Cell Death as a Biomarker in Predicting Prognosis and Therapeutic Response. | Cancers (Basel) | 2022 | 36497433 | PubTator, text mining | PubMed |
| Progress in Research on TLR4-Mediated Inflammatory Response Mechanisms in Brain Injury after Subarachnoid Hemorrhage. | Cells | 2022 | 36497041 | PubTator, text mining | PubMed |
| Meconium Aspiration Syndrome in Animal Models: Inflammatory Process, Apoptosis, and Surfactant Inactivation. | Animals (Basel) | 2022 | 36496831 | PubTator, text mining | PubMed |
| StripeDiff: Model-based algorithm for differential analysis of chromatin stripe. | Sci Adv | 2022 | 36475785 | PubTator, text mining | PubMed |
| Interruption of the long non-coding RNA HOTAIR signaling axis ameliorates chemotherapy-induced cachexia in bladder cancer. | J Biomed Sci | 2022 | 36471329 | PubTator, text mining | PubMed |
| Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma. | Front Immunol | 2022 | 36466923 | PubTator, text mining | PubMed |
| Thiocarbazate building blocks enable the construction of azapeptides for rapid development of therapeutic candidates. | Nat Commun | 2022 | 36443291 | PubTator, text mining | PubMed |
| Immunogenic cell death-related classifications in breast cancer identify precise immunotherapy biomarkers and enable prognostic stratification. | Front Genet | 2022 | 36437951 | PubTator, text mining | PubMed |
| Pharmacogenetics Role of Genetic Variants in Immune-Related Factors: A Systematic Review Focusing on mCRC. | Pharmaceutics | 2022 | 36432658 | PubTator, text mining | PubMed |
| Exposure to House Dust Mite Allergen and Endotoxin in Early Life and Sensitization and Allergic Rhinitis: The JECS. | Int J Environ Res Public Health | 2022 | 36429515 | PubTator, text mining | PubMed |
| Upregulated Immunogenic Cell-Death-Associated Gene Signature Predicts Reduced Responsiveness to Immune-Checkpoint-Blockade Therapy and Poor Prognosis in High-Grade Gliomas. | Cells | 2022 | 36429083 | PubTator, text mining | PubMed |
| Identification of Immunogenic Cell Death-Related Signature for Glioma to Predict Survival and Response to Immunotherapy. | Cancers (Basel) | 2022 | 36428756 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23643/papers?page=35